ExesaLiberoPharma was awarded a Phase I Small Business Technology

09/01/2019

ExesaLiberoPharma was awarded a Phase I Small Business Technology Transfer (STTR) grant from the National Institute for Arthritis and Musculoskeletal Diseases (NIAMS) of the National Institutes of Health